Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $93000.0.

  • Profound Medical's Depreciation & Amortization (CF) fell 4329.27% to $93000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $471000.0, marking a year-over-year decrease of 3652.29%. This contributed to the annual value of $707000.0 for FY2024, which is 275.1% down from last year.
  • Latest data reveals that Profound Medical reported Depreciation & Amortization (CF) of $93000.0 as of Q3 2025, which was down 4329.27% from $102000.0 recorded in Q2 2025.
  • Profound Medical's Depreciation & Amortization (CF)'s 5-year high stood at $199000.0 during Q1 2024, with a 5-year trough of $93000.0 in Q3 2025.
  • Over the past 3 years, Profound Medical's median Depreciation & Amortization (CF) value was $172000.0 (recorded in 2023), while the average stood at $158636.4.
  • As far as peak fluctuations go, Profound Medical's Depreciation & Amortization (CF) soared by 1117.32% in 2024, and later plummeted by 4456.52% in 2025.
  • Profound Medical's Depreciation & Amortization (CF) (Quarter) stood at $195000.0 in 2023, then fell by 17.95% to $160000.0 in 2024, then crashed by 41.88% to $93000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $93000.0 for Q3 2025, versus $102000.0 for Q2 2025 and $116000.0 for Q1 2025.